Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Study finds no (unique) industry bias in published trial results
Fierce Biotech
Monday, February 27, 2012 - 12:16pm
tags:
clinical trials
Jazz Pharma Earnings Seen Soaring; Stock Near High
Investors.com
Monday, February 27, 2012 - 12:15pm
tags:
earnings, Jazz Pharmaceuticals
Anacor Looks Right For A Long-Term Play
Seeking Alpha
Monday, February 27, 2012 - 12:14pm
tags:
Anacor
Withdrawn Painkillers & Responsive Generic Labeling
Pharmalot
Monday, February 27, 2012 - 12:03pm
tags:
generics, labeling, painkillers, Teva Pharmaceuticals, Watson, Mylan
Hepatitis C Remains A Hot Play
Seeking Alpha
Monday, February 27, 2012 - 12:01pm
tags:
hepatitis C, Bristol-Myers Squibb, Novartis, Gilead, Inhibitex, Merck, Vertex, Pharmasset, Enanta
Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval
TheStreet.com
Monday, February 27, 2012 - 11:09am
tags:
Chelsea Therapeutics, Northera, FDA
Clovis Oncology: Like the Story, Not the Stock
TheStreet.com
Monday, February 27, 2012 - 11:08am
tags:
Clovis Oncology
Advaxis Reports Positive Phase II Trial Results
Yahoo/Zacks
Monday, February 27, 2012 - 11:07am
tags:
Advaxism, ADXS-HPV, CIN 2/3
3 Highly Liquid Biotech Stocks Strongly Correlated To Volatility
Seeking Alpha
Monday, February 27, 2012 - 11:06am
tags:
Questcor, China Nuokang Bio, liquidity, Complete Genomics
Roche extends hostile bid for Illumina
Marketwatch
Monday, February 27, 2012 - 10:27am
tags:
Roche, hostile bid, M&A, Illumina
What Recalls? J&J CEO Gets A 55% Bonus Increase
Pharmalot
Monday, February 27, 2012 - 10:26am
tags:
William Weldon, executive pay, recalls, JNJ
Questcor Pharmaceuticals Beats Up on Analysts Yet Again
Motley Fool
Monday, February 27, 2012 - 10:25am
tags:
Questcor, earnings
ISTA Pharmaceuticals Misses on Revenues but Beats on EPS
Motley Fool
Monday, February 27, 2012 - 10:24am
tags:
ISTA Pharmaceuticals, earnings
Buffett says may consider selling J&J stock
Reuters
Monday, February 27, 2012 - 10:23am
tags:
JNJ, Warren Buffett
Auxilium Misses 4Q Estimates
Yahoo/Zacks
Monday, February 27, 2012 - 10:22am
tags:
Auxilium, earnings
China Biotech In Review: Newsummit To Stage $80 Million IPO On NYSE
Seeking Alpha
Monday, February 27, 2012 - 10:22am
tags:
China, IPOs, Newsummit Biopharma
GENFIT's drug candidate GFT505 gets patent protection from major countries
Pharmabiz
Saturday, February 25, 2012 - 10:02am
tags:
Genfit, GFT505, diabetes
Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler
Genetic Engineering News
Saturday, February 25, 2012 - 9:50am
tags:
Forest Labs, Colobreathe
U.K. enjoys bargain-basement drug prices, report finds
Fierce Pharma
Saturday, February 25, 2012 - 9:47am
tags:
drug prices
FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson's Disease
PharmaLive
Saturday, February 25, 2012 - 9:43am
tags:
Impax Laboratories, Parkinson's Disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.